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Teaching NeuroImages: Manganese neurotoxicity of the basal ganglia and thalamus A 27-year-old man with cholestasis presented with 4 weeks of progressive spastic quadriparesis and hypophonia. MRI revealed T2/fluid-attenuated inversion recovery hyperintensities in the basal ganglia and thalamus (figure 1). He was treated with IV methylprednisolone for acute disseminated encephalomyelitis. His condition worsened. MRI 4 weeks later showed larger symmetric hyperintensities in the basal ganglia and thalami (figure 2). Blood manganese was elevated (25.4 mg/L, reference 4.4-15.2). There was no known exposure. He was treated with chelation and levodopa with limited response.
This case represents manganese toxicity without known exposure. Cholestasis is a risk factor as manganese undergoes biliary excretion. Other workups were negative, including toxic (carbon monoxide, methanol), metabolic (hyperammonemia, osmotic myelinolysis), vascular (deep cerebral vein thrombosis), degenerative (pantothenate kinase-associated neurodegeneration), and infectious (flavivirus, toxoplasmosis) diseases.
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